| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 136 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 264.1K | $2.38M | - | |
| CFO | 145.1K | $1.31M | - | |
| VP | 112.7K | $1.01M | - | |
| VP | 34.9K | $313.9K | - | |
| Dir | 28.5K | $256.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Erck Stanley C86 | President And CEO | Sale+OE | 49,000 | $175.10 | $8,580,063.84 | -4.5% | -14.7% | -90.0% | |
| Oct 1, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 5,000 | $174.89 | $874,452.10 | -6.2% | -14.7% | -90.0% | |
| Sep 30, 2021 | Glenn Gregory M88 | President, R&D | Sell | 693 | $207.25 | $143,621.67 | -2.0% | -26.1% | -91.2% | |
| Sep 28, 2021 | Trizzino John86 | EVP, CCO And Cbo | Sale+OE | 7,501 | $209.92 | $1,574,637.13 | -8.1% | -23.0% | -90.4% | |
| Sep 27, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 2,083 | $234.43 | $488,315.17 | -3.2% | -31.7% | -91.3% | |
| Sep 27, 2021 | Trizzino John86 | EVP, CCO And Cbo | Sale+OE | 7,501 | $234.61 | $1,759,832.92 | -8.9% | -31.7% | -91.3% | |
| Sep 23, 2021 | Mott David M88 | Director | Sell | 24,961 | $252.90 | $6,312,616.20 | -9.6% | -28.8% | -91.8% | |
| Sep 21, 2021 | Trizzino John86 | EVP, CCO And Cbo | Sale+OE | 15,000 | $227.47 | $3,412,012.76 | -18.4% | -12.3% | -88.8% | |
| Sep 15, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 5,000 | $229.44 | $1,147,193.48 | -13.7% | -27.5% | -86.0% | |
| Sep 15, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 1,183 | $229.34 | $271,304.34 | -2.5% | -27.5% | -86.0% |